Paid Clinical Trials Olathe
Discover 422 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
M3814 with RadiotherapyTesting the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04172532
Conditions
Locally Advanced Pancreatic Adenocarcinoma
Stage III Pancreatic Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Computed Tomography
Hypofractionated Radiation Therapy
Magnetic Resonance Imaging
MVA-BN-WEVA Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Sponsor:
Bavarian Nordic
Location:
Code:
NCT06899802
Conditions
Encephalitis
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Accepted
Interventions
MVA-BN-WEV
Placebo
BMS-986460A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT06877702
Conditions
Healthy Volunteers
Eligibility Criteria
Sex: Male
Age: 18 - 60
Healthy Volunteers: Accepted
Interventions
BMS-986460
Abatacept ProductsComparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Sponsor:
Dr. Reddy's Laboratories Limited
Location:
Code:
NCT06126042
Conditions
Rheumatoid Arthritis
Eligibility Criteria
Sex: Male
Age: 18 - 50
Healthy Volunteers: Accepted
Interventions
Test Product
Reference product
Reference Medicinal Product
UTI VaccineA Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT06702449
Conditions
Urinary Tract Infections
Eligibility Criteria
Sex: All
Age: 18 - 64
Healthy Volunteers: Accepted
Interventions
Candidate UTI vaccine low dose formulation 1
Candidate UTI vaccine low dose formulation 2
Candidate UTI vaccine medium dose formulation 1
Candidate UTI vaccine medium dose formulation 2
Candidate UTI vaccine high dose formulation 1
BMS-986470A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT06481306
Conditions
Anemia, Sickle Cell
Healthy Volunteers
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
BMS-986470
Placebo
AdagrasibBioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets
Sponsor:
Mirati Therapeutics Inc.
Location:
Code:
NCT06801418
Conditions
Healthy Volunteers
Eligibility Criteria
Sex: All
Age: 18 - 60
Healthy Volunteers: Accepted
Interventions
Adagrasib
IMM01-STEMSafety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors with Obesity and Muscle Weakness
Sponsor:
Immunis, Inc.
Location:
Code:
NCT06600581
Conditions
Muscle Performance
Sarcopenic Obesity
Eligibility Criteria
Sex: All
Age: 60 - 70+
Healthy Volunteers: Not accepted
Interventions
IMM01-STEM
Placebo
IMM01-STEM alternating with placebo (saline)
Norovirus VaccineA Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old
Sponsor:
Vaxart
Location:
Code:
NCT06944717
Conditions
Norovirus Infections
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
VXA-G1.1-NN
VXA-G2.4-NS
VXA G1.1 NN-T
VXA G2.4 NS-T
Observational StudyRetail COVID-19 Study
Sponsor:
Biomedical Advanced Research and Development Authority
Location:
Code:
NCT06761612
Conditions
COVID - 19
Eligibility Criteria
Sex: All
Age: 3+
Healthy Volunteers: Accepted
Interventions
FDA approved mRNA vaccines